=== Turn 0: Author generates questions ===
Here are some novel undergraduate-level biology questions based on the specified criteria:

<question>
A clinical trial is evaluating the effectiveness of a new inhaler for asthma management. Patients are initially assessed for their medication adherence using the Morisky Medication Adherence Scale-8 (MMAS-8), where a score of 6 or higher indicates high adherence. Simultaneously, the Device Appropriateness Index (DAI) is used to evaluate the patient's ability to correctly use the inhaler. 60% of patients start with high adherence according to MMAS-8 (score >= 6). After an educational intervention focusing on inhaler technique, adherence (MMAS-8 >=6) improved to 85% among those who initially had high adherence. In a separate group who initially had lower adherence (MMAS-8 < 6), the educational intervention improved adherence to 40%. If the initial patient pool consists of 200 patients, how many patients now exhibit high medication adherence (MMAS-8 >= 6) after the intervention?
</question>

<question>
A respiratory therapist monitors a group of cystic fibrosis patients who use a nebulizer for mucolytic therapy. Initially, the average nebulizer usage is 3 times per day. An adherence assessment using electronic monitoring reveals that only 70% of patients use the nebulizer as prescribed. After implementing a counseling intervention combined with positive reinforcement, adherence increases by 30%.  Assuming the patient group consists of 50 patients, calculate the total number of nebulizer treatments *actually* administered per day in the patient group *after* the intervention.
</question>

<question>
A study investigates the relationship between medication adherence and lung function in COPD patients. Before intervention, the mean FEV1 (Forced Expiratory Volume in 1 second) is 1.8 liters. A cohort of 100 patients receives adherence-enhancing interventions, and their mean FEV1 increases by 15% over a six-month period. Calculate the new mean FEV1 in liters for the cohort after the intervention.
</question>

<question>
Researchers are developing an Adherence Index (AI) that combines data from electronic medication monitors and patient self-reports on inhaler usage. The AI is calculated as a weighted average, with medication behavior (electronically monitored) contributing 70% and device usage technique (self-reported and validated via observation) contributing 30%. A patient's electronic monitor shows 90% adherence to scheduled inhalations. However, observed inhaler technique reveals only 60% correct usage. Calculate the patient's Adherence Index (AI).
</question>

<question>
A pharmaceutical company is evaluating the impact of a new digital health intervention on medication adherence for patients with chronic respiratory disease.  A baseline survey indicates that 45% of patients are "highly adherent" to their prescribed inhaler regimen, defined as taking their medication at least 80% of the time. After implementation of the digital intervention, another survey reveals that this number has increased to 68%.  If the company initially surveyed 300 patients, how many *additional* patients are now classified as "highly adherent" following the intervention?
</question>
=== Turn 0: Critic feedback ===
Here's a critique of the provided questions, evaluated against your guidelines:

---

**Question 1**

<question>
A clinical trial is evaluating the effectiveness of a new inhaler for asthma management. Patients are initially assessed for their medication adherence using the Morisky Medication Adherence Scale-8 (MMAS-8), where a score of 6 or higher indicates high adherence. Simultaneously, the Device Appropriateness Index (DAI) is used to evaluate the patient's ability to correctly use the inhaler. 60% of patients start with high adherence according to MMAS-8 (score >= 6). After an educational intervention focusing on inhaler technique, adherence (MMAS-8 >=6) improved to 85% among those who initially had high adherence. In a separate group who initially had lower adherence (MMAS-8 < 6), the educational intervention improved adherence to 40%. If the initial patient pool consists of 200 patients, how many patients now exhibit high medication adherence (MMAS-8 >= 6) after the intervention?
</question>

**Critique:**
*   **Meets:** 1 (Scenario context is biological), 2 (Numerical answer), 4 (Problem to solve), 6 (Single solution), 7 (Rigorous phrasing), 9 (Single target).
*   **Needs Improvement:**
    *   **Guideline 3 (Force Multi-Step Reasoning - *Biological Principles*):** While multi-step calculation, the reasoning is purely arithmetic (proportions and sums). It does not require the application of two or more distinct biological principles or concepts beyond understanding the context. The question assesses quantitative literacy in a biological setting, not biological reasoning.
    *   **Guideline 5 (Be Unique):** The problem is a standard percentage calculation dressed in biological terms. It lacks conceptual depth in biology.

**Actionable Feedback:**
To improve, integrate a step that requires biological reasoning. For example, connect adherence levels to a physiological outcome (e.g., predicted change in FEV1 based on a given biological model) or a population health metric influenced by a biological principle.

---

**Question 2**

<question>
A respiratory therapist monitors a group of cystic fibrosis patients who use a nebulizer for mucolytic therapy. Initially, the average nebulizer usage is 3 times per day. An adherence assessment using electronic monitoring reveals that only 70% of patients use the nebulizer as prescribed. After implementing a counseling intervention combined with positive reinforcement, adherence increases by 30%. Assuming the patient group consists of 50 patients, calculate the total number of nebulizer treatments *actually* administered per day in the patient group *after* the intervention.
</question>

**Critique:**
*   **Meets:** 1 (Scenario context is biological), 2 (Numerical answer), 4 (Problem to solve), 7 (Generally rigorous phrasing), 9 (Single target).
*   **Needs Improvement:**
    *   **Guideline 3 (Force Multi-Step Reasoning - *Biological Principles*):** Similar to Q1, the reasoning is arithmetic. It does not involve distinct biological principles as reasoning steps.
    *   **Guideline 6 (Single Solution):** The phrase "adherence increases by 30%" is ambiguous. It could mean "increases *by* 30 percentage points" (e.g., from 70% to 100%) or "increases *by* 30% *of the initial adherence*" (e.g., 70% \* 1.30 = 91%). This ambiguity prevents a single, correct numerical answer.

**Actionable Feedback:**
Clarify the phrasing for percentage changes (e.g., "adherence increased by 30 percentage points" or "adherence increased to 91%"). As with Q1, integrate a step requiring biological reasoning beyond basic arithmetic, such as relating treatment frequency to a biochemical process affected by mucolytic therapy.

---

**Question 3**

<question>
A study investigates the relationship between medication adherence and lung function in COPD patients. Before intervention, the mean FEV1 (Forced Expiratory Volume in 1 second) is 1.8 liters. A cohort of 100 patients receives adherence-enhancing interventions, and their mean FEV1 increases by 15% over a six-month period. Calculate the new mean FEV1 in liters for the cohort after the intervention.
</question>

**Critique:**
*   **Meets:** 1 (Scenario context is biological), 2 (Numerical answer), 4 (Problem to solve), 6 (Single solution), 7 (Rigorous phrasing), 8 (Consistent units, standard notation), 9 (Single target).
*   **Needs Improvement:**
    *   **Guideline 3 (Force Multi-Step Reasoning):** This is a single-step calculation (1.8 \* 1.15). It does not involve two or more steps, nor does it require biological reasoning beyond recognizing FEV1 as a lung function measure.
    *   **Guideline 5 (Be Unique):** This is a very common "percentage increase" problem.

**Actionable Feedback:**
To force multi-step biological reasoning, consider:
1.  Providing multiple parameters (e.g., FEV1, FVC, TLC) and asking for a derived lung function ratio.
2.  Linking adherence to a change in FEV1 via a more complex biological model (e.g., a non-linear relationship or a threshold effect).
3.  Asking to calculate the number of patients whose FEV1 improved *above a clinical threshold* based on a given distribution and intervention effect.

---

**Question 4**

<question>
Researchers are developing an Adherence Index (AI) that combines data from electronic medication monitors and patient self-reports on inhaler usage. The AI is calculated as a weighted average, with medication behavior (electronically monitored) contributing 70% and device usage technique (self-reported and validated via observation) contributing 30%. A patient's electronic monitor shows 90% adherence to scheduled inhalations. However, observed inhaler technique reveals only 60% correct usage. Calculate the patient's Adherence Index (AI).
</question>

**Critique:**
*   **Meets:** 1 (Scenario context is biological), 2 (Numerical answer), 4 (Problem to solve), 6 (Single solution), 7 (Rigorous phrasing), 8 (Consistent units/index), 9 (Single target).
*   **Needs Improvement:**
    *   **Guideline 3 (Force Multi-Step Reasoning - *Biological Principles*):** While it's a two-step arithmetic calculation (two multiplications and one addition), it’s a direct application of a given formula. It does not require biological principles as reasoning steps or deeper conceptual understanding of the biological phenomena described.

**Actionable Feedback:**
To enhance biological reasoning, present the components of the Adherence Index as biological measures that need interpretation or transformation before being combined. For example, explain how different errors in technique lead to different levels of drug delivery and then ask for the combined therapeutic effectiveness, requiring biological understanding of drug absorption or lung mechanics.

---

**Question 5**

<question>
A pharmaceutical company is evaluating the impact of a new digital health intervention on medication adherence for patients with chronic respiratory disease. A baseline survey indicates that 45% of patients are "highly adherent" to their prescribed inhaler regimen, defined as taking their medication at least 80% of the time. After implementation of the digital intervention, another survey reveals that this number has increased to 68%. If the company initially surveyed 300 patients, how many *additional* patients are now classified as "highly adherent" following the intervention?
</question>

**Critique:**
*   **Meets:** 1 (Scenario context is biological), 2 (Numerical answer), 4 (Problem to solve), 6 (Single solution), 7 (Rigorous phrasing), 8 (Consistent unit), 9 (Single target).
*   **Needs Improvement:**
    *   **Guideline 3 (Force Multi-Step Reasoning - *Biological Principles*):** Similar to Q1, this is a multi-step arithmetic problem (calculate initial count, calculate final count, calculate difference). It lacks the integration of biological principles as reasoning steps.
    *   **Guideline 5 (Be Unique):** This is a very common "change in proportion" problem.

**Actionable Feedback:**
Embed this calculation within a larger biological problem. For instance, link the increase in highly adherent patients to a projected reduction in hospitalizations, requiring knowledge of disease progression or health economics in a biological context. Or, ask for the expected *drug consumption* increase if each adherent patient takes a certain dose, and then link that to pharmacokinetic principles.

---

**Overall Summary and General Advice for Improvement:**

The questions excel at setting a biological scenario and requiring numerical answers with clear phrasing. However, the core weakness across all questions is their failure to deeply integrate **biological principles into the multi-step reasoning process (Guideline 3)**. They predominantly function as quantitative literacy problems (percentages, weighted averages) *set within* a biological context, rather than questions that demand the application of biological knowledge for their solution.

To truly meet the "biology assessment expert" criteria for undergraduate-level biology, questions should:
1.  **Require biological interpretation or transformation of data.** Not just arithmetic.
2.  **Force the application of specific biological concepts or models.** (e.g., enzyme kinetics, physiological feedback loops, population dynamics, genetic probabilities, drug pharmacokinetics/pharmacodynamics).
3.  **Involve qualitative biological reasoning before quantitative calculation, or quantitative calculation that depends on a biological relationship.**

Consider structuring questions where a biological relationship or concept is implicitly or explicitly part of the calculation, rather than just the context. For example: "Given X biological input, how does Y biological process change, leading to Z measurable outcome?"
=== Turn 1: Author refines questions ===
Here are the improved questions, incorporating the feedback to strengthen the biological reasoning and multi-step nature of the problems:

<question>
A clinical trial is evaluating a novel inhaled corticosteroid (ICS) for asthma management. Patients are assessed for initial adherence using the MMAS-8. 60% of patients are initially considered highly adherent (MMAS-8 >= 6). An educational intervention improves adherence to 85% in the initially highly adherent group and to 40% in the initially less adherent group (MMAS-8 < 6). If the initial patient pool is 200, and assuming that each highly adherent patient uses an average of 180 puffs of the ICS per month and each less adherent patient uses 60 puffs per month, estimate the *overall* monthly change (increase or decrease) in ICS consumption in puffs for the entire patient pool *after* the adherence intervention. Consider that increased ICS usage leads to a minor improvement in predicted FEV1 which you do not need to explicitly calculate, but which helps justify the increased usage.
</question>

<question>
A respiratory therapist monitors cystic fibrosis patients using nebulized dornase alfa (a mucolytic). Initially, nebulizer usage is prescribed at 3 times daily. Electronic monitoring indicates 70% adherence. A counseling intervention increases adherence to 95% (defined as % of prescribed doses taken). Dornase alfa cleaves extracellular DNA, reducing sputum viscosity. Assume a simplified linear relationship: each nebulized dose reduces sputum viscosity by 10% (arbitrary units). If the average patient initially has a sputum viscosity of 100 units, calculate the *average* sputum viscosity of the patient group *after* the intervention, considering *both* the increased adherence and the mechanism of action of dornase alfa.
</question>

<question>
A study investigates adherence and lung function in COPD patients. Before intervention, mean FEV1 is 1.8 liters. 100 patients receive adherence-enhancing interventions. Spirometry reveals two subgroups: 60 patients show a 20% FEV1 improvement, while the remaining 40 show only a 5% improvement. Assume FEV1 is directly proportional to alveolar ventilation (Va). If normal Va is 4 L/min and dead space ventilation (Vd) is constant, calculate the *percentage increase* in the *overall* alveolar ventilation for the entire cohort, using the FEV1 changes as a proxy for Va improvement in each subgroup.
</question>

<question>
Researchers are developing an Adherence Index (AI). Electronic monitors show 90% adherence to scheduled inhalations of albuterol (a short-acting beta2-agonist). Observed inhaler technique reveals only 60% correct usage. Correct technique ensures 95% of the drug reaches the small airways, while incorrect technique leads to only 40% deposition. If albuterol's bronchodilatory effect is directly proportional to the amount reaching the small airways, calculate the *overall effective drug delivery* percentage for this patient, considering both adherence and technique. Present this value as the patient's Adherence Index (AI), understanding that AI directly reflects drug delivery, not just behavior.
</question>

<question>
A pharmaceutical company evaluates a digital health intervention's impact on medication adherence for chronic respiratory disease (Inhaled Long Acting Beta Agonist + Inhaled Corticosteroid combination inhaler). A baseline survey shows 45% of patients are "highly adherent" (>=80% adherence). Post-intervention, this increases to 68%. If the initial survey was of 300 patients, and each highly adherent patient avoids an average of 0.25 hospital admissions per year, and each non-adherent patient averages 0.75 hospital admissions per year, calculate the *overall reduction* in expected hospital admissions per year within the surveyed group after the intervention, considering that the change in hospitalization rate is due to the change in *adherence behaviour*.
</question>
=== Turn 1: Critic feedback ===
Here's a critique of each question against your guidelines, with concise, actionable feedback:

<question>
A clinical trial is evaluating a novel inhaled corticosteroid (ICS) for asthma management. Patients are assessed for initial adherence using the MMAS-8. 60% of patients are initially considered highly adherent (MMAS-8 >= 6). An educational intervention improves adherence to 85% in the initially highly adherent group and to 40% in the initially less adherent group (MMAS-8 < 6). If the initial patient pool is 200, and assuming that each highly adherent patient uses an average of 180 puffs of the ICS per month and each less adherent patient uses 60 puffs per month, estimate the *overall* monthly change (increase or decrease) in ICS consumption in puffs for the entire patient pool *after* the adherence intervention. Consider that increased ICS usage leads to a minor improvement in predicted FEV1 which you do not need to explicitly calculate, but which helps justify the increased usage.
</question>
**Critique:**
*   **Guideline 1 (Biology Scenario):** Good. Realistic clinical trial context.
*   **Guideline 3 (Multi-Step Reasoning):** Good. Requires calculating initial and final consumption based on shifting adherence groups.
*   **Guideline 7 (Rigorous, Concise Phrasing):** Weakness. The last sentence ("Consider that increased ICS usage...") is extraneous as it's explicitly stated not to be calculated. It adds noise without contributing to the problem-solving or demonstrating deeper biological understanding relevant to the calculation.
*   **Biological Reasoning Depth:** While the context is biological (asthma, ICS, FEV1), the core calculation is a statistical/arithmetic problem about patient groups and consumption rates, rather than a direct biological mechanism.

**Actionable Feedback:**
*   Remove the sentence: "Consider that increased ICS usage leads to a minor improvement in predicted FEV1 which you do not need to explicitly calculate, but which helps justify the increased usage." This improves conciseness and removes irrelevant information for the requested calculation.

---

<question>
A respiratory therapist monitors cystic fibrosis patients using nebulized dornase alfa (a mucolytic). Initially, nebulizer usage is prescribed at 3 times daily. Electronic monitoring indicates 70% adherence. A counseling intervention increases adherence to 95% (defined as % of prescribed doses taken). Dornase alfa cleaves extracellular DNA, reducing sputum viscosity. Assume a simplified linear relationship: each nebulized dose reduces sputum viscosity by 10% (arbitrary units). If the average patient initially has a sputum viscosity of 100 units, calculate the *average* sputum viscosity of the patient group *after* the intervention, considering *both* the increased adherence and the mechanism of action of dornase alfa.
</question>
**Critique:**
*   **Guideline 1 (Biology Scenario):** Excellent. Integrates specific disease (CF), drug (dornase alfa), and mechanism (DNA cleavage, sputum viscosity).
*   **Guideline 3 (Multi-Step Reasoning):** Excellent. Requires calculating actual doses, then applying a biological effect (viscosity reduction) to determine the final state.
*   **Guideline 6 (Single Solution):** Weakness. The phrase "reduces sputum viscosity by 10%" combined with "simplified linear relationship" could still be ambiguous. Does it mean 10% of the *initial* value (10 units per dose) or 10% *of the current remaining viscosity*? The "linear relationship" strongly suggests the former (additive/subtractive fixed amount), but explicit clarification would remove all doubt for a rigorous assessment.
*   **Biological Reasoning Depth:** Strong, directly links drug mechanism to physiological outcome.

**Actionable Feedback:**
*   Clarify the linear relationship: "Assume a simplified linear relationship where each nebulized dose reduces sputum viscosity by a fixed amount equivalent to 10% of the initial 100 units (i.e., 10 units per dose)." This eliminates ambiguity and ensures a single correct solution.

---

<question>
A study investigates adherence and lung function in COPD patients. Before intervention, mean FEV1 is 1.8 liters. 100 patients receive adherence-enhancing interventions. Spirometry reveals two subgroups: 60 patients show a 20% FEV1 improvement, while the remaining 40 show only a 5% improvement. Assume FEV1 is directly proportional to alveolar ventilation (Va). If normal Va is 4 L/min and dead space ventilation (Vd) is constant, calculate the *percentage increase* in the *overall* alveolar ventilation for the entire cohort, using the FEV1 changes as a proxy for Va improvement in each subgroup.
</question>
**Critique:**
*   **Guideline 1 (Biology Scenario):** Excellent. COPD, FEV1, alveolar ventilation, dead space – all highly relevant biological concepts.
*   **Guideline 3 (Multi-Step Reasoning):** Excellent. Requires calculating FEV1/Va for each subgroup, then averaging for the cohort and determining percentage change.
*   **Guideline 7 (Rigorous, Concise Phrasing):** Excellent. The mention of normal Va and Vd, while not directly used in the percentage calculation, provides valuable biological context and encourages students to discern relevant information.
*   **Biological Reasoning Depth:** Strong, directly linking FEV1 changes to alveolar ventilation, a key physiological parameter.

**Actionable Feedback:**
*   No significant improvements needed. This is a very well-designed question.

---

<question>
Researchers are developing an Adherence Index (AI). Electronic monitors show 90% adherence to scheduled inhalations of albuterol (a short-acting beta2-agonist). Observed inhaler technique reveals only 60% correct usage. Correct technique ensures 95% of the drug reaches the small airways, while incorrect technique leads to only 40% deposition. If albuterol's bronchodilatory effect is directly proportional to the amount reaching the small airways, calculate the *overall effective drug delivery* percentage for this patient, considering both adherence and technique. Present this value as the patient's Adherence Index (AI), understanding that AI directly reflects drug delivery, not just behavior.
</question>
**Critique:**
*   **Guideline 1 (Biology Scenario):** Outstanding. Integrates pharmacology (albuterol), physiology (small airways, bronchodilation), and clinical practice (adherence, technique, drug deposition).
*   **Guideline 3 (Multi-Step Reasoning):** Excellent. Requires careful calculation of conditional probabilities and fractional drug delivery from multiple factors.
*   **Guideline 5 (Be Unique):** Excellent. This is a novel, practical, and conceptually rich problem.
*   **Biological Reasoning Depth:** Very strong, directly modeling the complex interplay of patient behavior and drug delivery/efficacy.

**Actionable Feedback:**
*   No significant improvements needed. This is an exemplary question.

---

<question>
A pharmaceutical company evaluates a digital health intervention's impact on medication adherence for chronic respiratory disease (Inhaled Long Acting Beta Agonist + Inhaled Corticosteroid combination inhaler). A baseline survey shows 45% of patients are "highly adherent" (>=80% adherence). Post-intervention, this increases to 68%. If the initial survey was of 300 patients, and each highly adherent patient avoids an average of 0.25 hospital admissions per year, and each non-adherent patient averages 0.75 hospital admissions per year, calculate the *overall reduction* in expected hospital admissions per year within the surveyed group after the intervention, considering that the change in hospitalization rate is due to the change in *adherence behaviour*.
</question>
**Critique:**
*   **Guideline 1 (Biology Scenario):** Good. Relevant clinical scenario linking adherence to a critical health outcome.
*   **Guideline 3 (Multi-Step Reasoning):** Good. Requires calculating admissions before and after intervention based on adherence shifts.
*   **Biological Reasoning Depth:** The biological depth is in the clinical consequence (hospital admissions reduced by adherence) rather than a direct physiological mechanism in the calculation itself. It's more of a health economics/epidemiology problem rooted in biological outcomes.

**Actionable Feedback:**
*   No significant improvements needed. It's a strong question demonstrating the broader impact of adherence on clinical outcomes.
=== Turn 2: Author refines questions ===
Here are the refined questions, incorporating the feedback:

<question>
A clinical trial is evaluating a novel inhaled corticosteroid (ICS) for asthma management. Patients are assessed for initial adherence using the MMAS-8. 60% of patients are initially considered highly adherent (MMAS-8 >= 6). An educational intervention improves adherence to 85% in the initially highly adherent group and to 40% in the initially less adherent group (MMAS-8 < 6). If the initial patient pool is 200, and assuming that each highly adherent patient uses an average of 180 puffs of the ICS per month and each less adherent patient uses 60 puffs per month, estimate the *overall* monthly change (increase or decrease) in ICS consumption in puffs for the entire patient pool *after* the adherence intervention.
</question>

<question>
A respiratory therapist monitors cystic fibrosis patients using nebulized dornase alfa (a mucolytic). Initially, nebulizer usage is prescribed at 3 times daily. Electronic monitoring indicates 70% adherence. A counseling intervention increases adherence to 95% (defined as % of prescribed doses taken). Dornase alfa cleaves extracellular DNA, reducing sputum viscosity. Assume a simplified linear relationship where each nebulized dose reduces sputum viscosity by a fixed amount equivalent to 10% of the initial 100 units (i.e., 10 units per dose). If the average patient initially has a sputum viscosity of 100 units, calculate the *average* sputum viscosity of the patient group *after* the intervention, considering *both* the increased adherence and the mechanism of action of dornase alfa.
</question>

<question>
A study investigates adherence and lung function in COPD patients. Before intervention, mean FEV1 is 1.8 liters. 100 patients receive adherence-enhancing interventions. Spirometry reveals two subgroups: 60 patients show a 20% FEV1 improvement, while the remaining 40 show only a 5% improvement. Assume FEV1 is directly proportional to alveolar ventilation (Va). If normal Va is 4 L/min and dead space ventilation (Vd) is constant, calculate the *percentage increase* in the *overall* alveolar ventilation for the entire cohort, using the FEV1 changes as a proxy for Va improvement in each subgroup.
</question>

<question>
Researchers are developing an Adherence Index (AI). Electronic monitors show 90% adherence to scheduled inhalations of albuterol (a short-acting beta2-agonist). Observed inhaler technique reveals only 60% correct usage. Correct technique ensures 95% of the drug reaches the small airways, while incorrect technique leads to only 40% deposition. If albuterol's bronchodilatory effect is directly proportional to the amount reaching the small airways, calculate the *overall effective drug delivery* percentage for this patient, considering both adherence and technique. Present this value as the patient's Adherence Index (AI), understanding that AI directly reflects drug delivery, not just behavior.
</question>

<question>
A pharmaceutical company evaluates a digital health intervention's impact on medication adherence for chronic respiratory disease (Inhaled Long Acting Beta Agonist + Inhaled Corticosteroid combination inhaler). A baseline survey shows 45% of patients are "highly adherent" (>=80% adherence). Post-intervention, this increases to 68%. If the initial survey was of 300 patients, and each highly adherent patient avoids an average of 0.25 hospital admissions per year, and each non-adherent patient averages 0.75 hospital admissions per year, calculate the *overall reduction* in expected hospital admissions per year within the surveyed group after the intervention, considering that the change in hospitalization rate is due to the change in *adherence behaviour*.
</question>
=== Final questions generated ===
